Effects of Thalidomide on the Expression of Adhesion Molecules in Experimental Hepatic Fibrotic Rats
Peng Lü,He-sheng Luo,C P Shelley,Yan-ju Xiao,Shi-quan Liu
DOI: https://doi.org/10.3760/j.issn:1007-3418.2006.08.011
2006-01-01
Abstract:Objective To study the therapeutic effect of thalidomide on liver fibrosis in rats and its effect on the expression of ICAM-1,VCAM-1 and E-selectin.Methods Liver fibrosis of rat was induced by intraperitoneal injection with carbon tetrachloride (CCl_4) for 4 weeks. The dynamic change of liver fibrosis were observed at different time points(2wk, 4wk, 6wk after using 100mg/kg thalidomide by intragastric administration). The histopathology of liver was examined by HE staining. Serum hyaluronic acid(HA), laminin(LN), procollagen type Ⅲ(PCⅢ)and collagen type Ⅳ ( C Ⅳ)were detected by radioimmunoassay. The expression of ICAM-1, VCAM-1 and E-selectin were examined by immunohistochemistry staining. Results Compared with the liver fibrosis group, thalidomide(4 weeks or 6 weeks) improved the liver histopathological alteration significantly. Serum HA, LN, PCⅢ and C Ⅳ of the rats in the group-treated with thalidomide for 4 weeks or 6 weeks were significantly lower than those in liver fibrosis group (P0.05). The expressions of ICAM-1, VCAM-1 and E-selectin protein were significantly reduced in thalidomide-treated groups (2 weeks, 4 weeks, or 6 weeks), compared with those in liver fibrosis group (P0.05). Conclusion Thalidomide can effectively reverse the liver fibrosis of rats. Its effect on the expression of ICAM-1, VCAM-1 and E-selectin may be one of its mechanisms.